Canada Dupuytren’s Disease Market Size & Outlook, 2022-2030
The dupuytren’s disease market in Canada is expected to reach a projected revenue of US$ 95.4 million by 2030. A compound annual growth rate of 6.4% is expected of Canada dupuytren’s disease market from 2023 to 2030.
Revenue, 2022 (US$M)
$58.3
Forecast, 2030 (US$M)
$95.4
CAGR, 2023 - 2030
6.3%
Report Coverage
Canada
Canada dupuytren’s disease market, 2018-2030 (US$M)
Related Markets
Canada dupuytren’s disease market highlights
- The Canada dupuytren’s disease market generated a revenue of USD 58.3 million in 2022 and is expected to reach USD 95.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 6.4% from 2023 to 2030.
- In terms of segment, type ii was the largest revenue generating disease type in 2022.
- Type II is the most lucrative disease type segment registering the fastest growth during the forecast period.
Dupuytren’s disease market data book summary
| Market revenue in 2022 | USD 58.3 million |
| Market revenue in 2030 | USD 95.4 million |
| Growth rate | 6.4% (CAGR from 2022 to 2030) |
| Largest segment | Type ii |
| Fastest growing segment | Type II |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type I, Type II, Type III |
| Key market players worldwide | Bayer AG, Novartis AG ADR, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, AstraZeneca PLC, Hikma Pharmaceuticals PLC, LEO Pharma, Fresenius SE & Co KGaA, Nantong Jinghua Pharmaceutical, Actiza Pharmaceutical Pvt. Ltd, Eppendorf, Endo Pharmaceuticals, Spear Pharmaceuticals |
Other key industry trends
- In terms of revenue, Canada accounted for 1.4% of the global dupuytren’s disease market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. dupuytren’s disease market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 95.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dupuytren’s Disease Market Scope
Dupuytren’s disease market segmentation & scope
Dupuytren’s Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada dupuytren’s disease market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupuytren’s disease market will help companies and investors design strategic landscapes.
Type ii was the largest segment with a revenue share of 62.44% in 2022. Horizon Databook has segmented the Canada dupuytren’s disease market based on type i, type ii, type iii covering the revenue growth of each sub-segment from 2018 to 2030.
- Canada Dupuytren’s Disease Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Type I
- Type II
- Type III
- Canada Dupuytren’s Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Diagnosis
- Treatment
- Canada Dupuytren’s Disease End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinics
- Academic & Research
- Other End Users
Reasons to subscribe to Canada dupuytren’s disease market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada dupuytren’s disease market databook
-
Our clientele includes a mix of dupuytren’s disease market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada dupuytren’s disease market, including forecasts for subscribers. This country databook contains high-level insights into Canada dupuytren’s disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada dupuytrens disease market report size, by disease type, 2018-2030 (US$M)
Canada Dupuytren’s Disease Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
